Showing results (31-40 of 181) with videos related to
Sort By:
Pageof 19
Transplantation|June 11, 2011
Correlations between pretransplant dialysis duration, bladder capacity, and prevalence of vesicoureteral reflux to the graftTakamitsu Inoue, Shigeru Satoh, Mitsuru Saito, et al.International Journal of Clinical Oncology|December 17, 2010
A case study of metastatic Xp11.2 translocation renal cell carcinoma effectively treated with sunitinibKazuyuki Numakura, Norihiko Tsuchiya, Takeshi Yuasa, et al.Hinyokika Kiyo. Acta Urologica Japonica|July 26, 2016
[Extrarenal Retroperitoneal Angiomyolipoma Masquerading as Retroperitoneal Liposarcoma : A Report of Two Cases]Ryohei Yamamoto, Takamitsu Inoue, Kazuyuki Numakura, et al.Japanese Journal of Clinical Oncology|February 17, 2021
Efficacy and safety of subsequent molecular targeted therapy after immuno-checkpoint therapy, retrospective study of Japanese patients with metastatic renal cell carcinoma (AFTER I-O study)Yoshihiko Tomita, Go Kimura, Satoshi Fukasawa, et al.World Journal of Surgical Oncology|June 14, 2022
Factors influencing warm ischemia time in robot-assisted partial nephrectomy change depending on the surgeon's experienceKazuyuki Numakura, Mizuki Kobayashi, Atsushi Koizumi, et al.International Cancer Conference Journal|September 9, 2020
Robotic-assisted laparoscopic partial nephrectomy for renal cell carcinoma in horseshoe kidney: a hybrid technique with conventional laparoscopic surgeryKazuyuki Numakura, Yumina Muto, Ryohei Yamamoto, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|March 19, 2016
Influence of everolimus on the pharmacokinetics of tacrolimus in Japanese renal transplant patientsTakenori Niioka, Hideaki Kagaya, Mitsuru Saito, et al.Transplantation|October 18, 2012
Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantationTakenori Niioka, Shigeru Satoh, Hideaki Kagaya, et al.Japanese Journal of Clinical Oncology|August 5, 2021
Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinomaYoshihiko Tomita, Go Kimura, Satoshi Fukasawa, et al.Asian Journal of Endoscopic Surgery|July 6, 2021
Comparison of parenchymal volume loss assessed by three-dimensional computed tomography volumetry and renal functional recovery between conventional and robot-assisted laparoscopic partial nephrectomySohei Kanda, Takamitsu Inoue, Shiori Nakajima, et al.Pageof 19